MPP+ depletes retinal dopamine and induces D-1 receptor supersensitivity

This publication has 11 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Neurotoxins, parkinsonism and Parkinson's disease
  Pharmacology & Therapeutics, 1987
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina
  Neuroscience Letters, 1986
• Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density
  Brain Research, 1986
• Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra
  European Journal of Pharmacology, 1986
• Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum
  Neuroscience Letters, 1985
• Psoralens Increase the Concentration of Cyclic AMP in Human Cells In Vitro
  Journal of Investigative Dermatology, 1985
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Catecholamine systems of retina: A model for studying synaptic mechanisms
  Life Sciences, 1984
• Epinephrine: A Potential Neurotransmitter in Retina
  Journal of Neurochemistry, 1983